Methodist Hosp. of Indiana

Indianapolis, Indiana 46202-5250

0 studies enrolling now · 33 studies all time

What they study most

Candidiasis, Oral, Cryptosporidiosis, Cytomegalovirus Infections, Diabetes Mellitus, HIV Infections, Hepatitis C, Hypercholesterolemia, Hypertriglyceridemia, Lipodystrophy, Meningitis, Cryptococcal, Mycobacterium Avium-intracellulare Infection, Peripheral Nervous System Disease

Studies at this site

• Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine — Completed
• A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past — Completed
• A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy — Completed
• Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis — Completed
• A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3 — Completed
• The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks — Completed
• A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS — Completed
• A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis — Completed
• A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3 — Completed
• A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole — Completed
• The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients — Completed
• A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS — Completed
• A Study of HIV-Disease Development in Aging — Completed
• Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV — Completed
• Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination — Completed
• A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) — Completed
• Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat — Completed
• Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV — Completed
• Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People — Completed
• Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs — Completed
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients — Completed
• A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection — Completed
• A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients — Completed
• A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV — Completed
• Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis — Completed
• Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs — Completed
• Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients — Completed
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection — Completed
• Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen — Completed
• Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients — Completed
• Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection — Completed
• Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor — Completed
• The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients — Completed